KBI Biopharma News and Activities

KBI Biopharma is owned by JSR.

JSR is a company listed under the stock ticker 4185 (JP).

JSR has a direct presence in 3 countries.

JSR has 5 subsidiaries including Crown Bioscience, Indivumed Services and Inpria.

They are in:

• Biotechnology67%
• Chemicals17%
• Other17%

View the org chart displaying its 15 main executives

Most searched biographies at KBI Biopharma

• Tim Lowery, Chief Executive Officer
• Katherine Wolf, Chief Financial Officer
• Debra Bruneau, Chief People Officer

Create your alert
to follow the executive moves at KBI Biopharma.

JSR has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by KBI Biopharma

• KBI Biopharma to Lead Development and Manufacturing of Alanis Therapeutics’ Antagonistic Antibody Candidate
• Following a Successful FDA Inspection, KBI Biopharma Extends and Expands Commercial Contract with Leading Global Pharmaceutical Company
• KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer
• KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer
• KBI Biopharma Recognized as a Leader in All Six Categories of the 2024 CDMO Leadership Awards
• KBI Biopharma, Inc. and Argonaut Manufacturing Services, Inc. Forge Strategic Alliance to Support Global Biopharmaceutical Companies with Integrated Drug Substance and Drug Product Solutions
• KBI Biopharma, Inc. Appoints Maggie Chen as Site Head of Patriot Park Mammalian cGMP Manufacturing Facility
• KBI Biopharma, Inc. Expands Global Portfolio with Launch of SUREmAb™ for Faster Monoclonal Antibody Development and Manufacturing
• KBI Biopharma Continues to Strengthen Leadership and Expertise With Key Executive Appointments
• KBI's Leadership Team Discusses Operational Consolidation with Selexis at BIO International 2023
• View more press releases Close

Social media about KBI Biopharma

• KBI Biopharma on Wikipedia, Google News & Yahoo Finance
• KBI Biopharma on LinkedIn, X (Twitter) & YouTube